Published in Clinical Oncology Week, May 30th, 2005
In a recent article published in the journal Archives of Dermatology, scientists in England conducted a study "to evaluate the long-term efficacy of systemic retinoids in reducing the incidence of cutaneous SCCs in OTRs, who are at greatly increased risk of SCCs."
"A retrospective before-after study of OTRs who had received low-dose systemic retinoids during 1 to 16 years for prevention of SCCs [in] a specialist dermatology clinic for organ transplant recipients at St. Bartholomew's and the Royal London Hospital [was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.